Multiple Sclerosis Trial, Recruiting (NCT06640660)

Multiple Sclerosis Trial, Recruiting NCT06640660 Sponsor: IRCCS San Camillo, Venezia, Italy Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT06640660 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Multiple Sclerosis OR West Nile virus infection, confirmed by a lab test, and this diagnosis was made no more than 12 months before you were admitted to hospital
You can still use at least one hand normally
Your vision is normal, or you can see normally with glasses or contact lenses

Who may not be able to join:

You have a history of mental health (psychiatric) conditions and/or other neurological diseases happening at the same time
You are not able to give your own informed consent to take part in the trial
You have difficulty understanding spoken instructions

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06640660

Sponsor: IRCCS San Camillo, Venezia, Italy

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

More information: https://clinicaltrials.gov/study/NCT06640660

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Multiple Sclerosis OR West Nile virus infection, confirmed by a lab test, and this diagnosis was made no more than 12 months before you were admitted to hospital
You can still use at least one hand normally
Your vision is normal, or you can see normally with glasses or contact lenses

Who may not be able to join:

You have a history of mental health (psychiatric) conditions and/or other neurological diseases happening at the same time
You are not able to give your own informed consent to take part in the trial
You have difficulty understanding spoken instructions

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

IRCCS San Camillo, Venezia, Italy

Registry

ClinicalTrials.gov

Start date

21 September 2022

Est. completion

30 December 2024

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Measure of changes in cognitive performance after the treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov